RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Sep 15, 2017 - 4:49:58 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Novel imaging could better identify patients who would benefit from ICDs

May 10, 2012 - 4:00:00 AM

The current research study is a prime example of translational medicine because it came directly out of the laboratory research the UB researchers had performed in animals with chronic ischemic heart disease. These preclinical studies demonstrated that the risk of developing ventricular fibrillation was related to regional myocardial denervation.


 
[RxPG] BUFFALO, N.Y. -- New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD).

ICDs are used to prevent sudden cardiac arrest in patients with advanced heart disease, but many patients' devices are never triggered. New research suggests that imaging the loss of nerve function in the heart may identify those patients at greatest risk of developing a life-threatening arrhythmia.

That finding is being reported today (May 10 at 11 a.m. ET) as a Late-Breaking Clinical Trial at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston.

The UB PAREPET study, or Prediction of Arrhythmic Events with Positron Emission Tomography, is the largest PET imaging study ever done on sudden cardiac arrest.

UB researchers used PET imaging to quantify the patients' amount of denervated myocardium, where sympathetic nerves in the heart have died or become damaged due to inadequate blood flow. This was accomplished by imaging the heart's ability to take up a radioactive tracer of norepinephrine, the neurotransmitter released from the heart's neurons, using the cyclotron-generated radiopharmaceutical 11C-hydroxyephedrine.

The principal question we posed with this study was whether the amount of denervated myocardium could predict sudden cardiac arrest, says James A. Fallavollita, MD, UB professor of medicine and lead author on the study. We found that when at least 38 percent of the heart was denervated, there was a significant increase in the risk of sudden cardiac arrest.

Ultimately, we wanted to develop an approach that could tackle the problem of identifying a larger portion of the patients with coronary artery disease who are at risk of developing sudden cardiac arrest, explains John M. Canty Jr., MD, the Albert and Elizabeth Rekate Professor of Medicine in the UB School of Medicine and Biomedical Sciences and UB's chief of cardiovascular medicine, who was principal investigator of the research. Since many patients who suffer a cardiac arrest do not have severely depressed heart function, PET imaging may be able to identify high risk individuals who, in the future, could be considered candidates for an ICD.

A photograph of Canty is at

Currently, the main criteria for determining who gets an ICD is a measurement of heart function called the ejection fraction, which is the percentage of blood pumped by the heart with each beat. Individuals with an ejection fraction of 35 percent or less are considered candidates for ICDs because they have a significant risk of sudden cardiac arrest.

Funded by the National Institutes of Health, PAREPET involved 204 patients from Western New York with advanced heart disease.

The current research study is a prime example of translational medicine because it came directly out of the laboratory research the UB researchers had performed in animals with chronic ischemic heart disease. These preclinical studies demonstrated that the risk of developing ventricular fibrillation was related to regional myocardial denervation.

This is as clear an example of translational medicine as there is, with a project being taken from bench-to-bedside by the same investigative team, says Canty. In our preclinical research, we studied factors that lead to sudden cardiac arrest in animals. This led directly to the human study. This important finding may ultimately impact the care of patients with heart disease.



Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

Online ACLS Certification

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)